Colgate Announces 1st Quarter 2014 Results
Strong Organic Sales Growth Worldwide
Net income and Diluted earnings per share in first quarter 2014 were
Net income and Diluted earnings per share in first quarter 2013 were
Excluding the above noted items in both periods, Net income in first
quarter 2014 was
Gross profit margin was 58.4% in first quarter 2014 versus 58.3% in the year ago quarter. Excluding the above noted items in both periods, Gross profit margin was 58.6% in first quarter 2014, even with the year ago quarter, as higher pricing, cost savings from the Company's funding-the-growth initiatives and cost savings from the 2012 Restructuring Program were offset by higher raw and packaging material costs, which included the impact of foreign exchange transaction costs.
Selling, general and administrative expenses were 35.7% of Net sales in
first quarter 2014 versus 35.6% of Net sales in first quarter 2013.
Excluding the above noted items in both periods, Selling, general and
administrative expenses decreased by 10 basis points to 35.3% of Net
sales in first quarter 2014, as lower overhead expenses were partially
offset by increased advertising investment, both as a percentage of Net
sales. Worldwide advertising investment increased 1.5% versus the year
ago quarter to
Operating profit decreased 15% to
Net cash provided by operations year to date was
"All operating divisions contributed to the strong 6.5% organic sales growth, led by the emerging markets where organic sales grew a robust 10.0%.
"Advertising investment increased versus year ago, both absolutely and as a percent to sales, and we continue to plan for higher levels of advertising investment in the balance of the year in support of a very full pipeline of new products worldwide.
"Colgate's leading global market shares in toothpaste and manual toothbrushes remain strong at 44.3% and 33.1%, respectively, on a year-to-date basis. We continue to make great progress in mouthwash, with our global market share in that category reaching a record high at 17.3% year to date, up 60 basis points versus the year ago period.
"We expect our growth momentum to continue as we progress through the year. Our 2012 Restructuring Program is on track and proceeding smoothly. We also continue to be sharply focused on our aggressive funding-the-growth programs and our strategic worldwide pricing initiatives."
As previously disclosed,
In closing,
At
The following are comments about divisional performance for first quarter 2014 versus the year ago period. See attached Geographic Sales Analysis Percentage Changes and Segment Information schedules for additional information on divisional net sales and operating profit.
North
Operating profit in
In the U.S., new product launches are contributing to volume growth.
Market share gains year to date were seen in manual toothbrushes,
mouthwash, dish liquids, liquid cleaners and fabric conditioners. In
toothpaste, Colgate Optic White, Colgate Optic White Dual Action,
Colgate Optic White Platinum Whiten and Protect, Colgate Total Advanced
Clean and Tom's of
In manual toothbrushes, Colgate continued its brand market leadership in the U.S. with its market share in that category reaching a record 41.9% year to date, up 4.5 share points versus the year ago period. This success was driven by strong sales of Colgate 360° Optic White Toothbrush + Built-In Whitening Pen, Colgate 360° Optic White, Colgate 360° Total Advanced Floss Tip bristles and Colgate Slim Soft manual toothbrushes.
Successful products driving volume growth in the U.S. in other categories include Colgate Total Advanced Pro-Shield and Colgate Optic White mouthwashes, Speed Stick Gear deodorants with new DryCore technology, Softsoap brand Décor Collection liquid hand soaps, Suavitel Fast Dry fabric conditioner and Palmolive Dish & Sink dish washing liquid.
Latin
Operating profit in
Colgate's strong leadership in toothpaste throughout
Products in other categories contributing to volume growth include
Protex Men, Protex Vitamin E, Protex Omega 3 and Palmolive Naturals
Olive and Aloe bar soaps, Palmolive Naturals Argan Oil hair care and
Operating profit in
Colgate strengthened its oral care leadership in the
Recent premium innovations contributing to volume growth in other product categories include elmex Sensitive Professional, elmex Junior and Colgate Plax Complete Care mouthwashes, Sanex Surgras and Palmolive Mediterranean Moments shower gels, Sanex Dermo No Perfume deodorant, Palmolive Hygiene-Plus liquid hand soap, Paic Excel + dish liquid and Soupline Perfect Glide fabric conditioner.
Asia (15% of Company Sales)
Operating profit in
Colgate continued its toothpaste leadership in
Successful new products contributing to volume growth in other
categories in the region include Colgate Slim Soft Charcoal and Colgate
360° Interdental manual toothbrushes,
Operating profit in
Colgate continued its toothpaste leadership in
Hill's Pet Nutrition (13% of Company Sales)
Hill's Net sales increased 3.5% during first quarter 2014. Unit volume
increased 3.5% with 2.0% higher pricing and 2.0% negative foreign
exchange. Volume gains in
Hill's Operating profit increased 6% in first quarter 2014 to
New product introductions driving volume growth in the U.S. include Hill's Ideal Balance Slim & Healthy, Feline Indoor and Hairball, Hill's Science Diet Perfect Weight, Grain Free and Sensitive Stomach and Skin, and Hill's Prescription Diet Metabolic.
New product introductions driving volume growth internationally include Hill's Prescription Diet Metabolic and c/d Urinary Stress, Hill's Ideal Balance, Hill's Science Plan Small & Miniature Breed, and the relaunch of Hill's Science Diet with improved taste.
Exciting new products planned for launch in second quarter 2014 include Hill's Prescription Diet c/d Multicare Ocean Fish Flavor and Prescription Diet Stews leveraging breakthrough technology in the therapeutic canned food segment.
***
About
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data. Market share data is subject to limitations on the availability of up-to-date information. We believe that the third-party vendors we use to provide data are reliable, but we have not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information calculated by the Company may be different from market share information calculated by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
Explanatory Note Regarding Currency Neutral Estimates
Management's estimate of earnings per share growth in 2014 on a currency neutral basis eliminates the impact of period-over-period changes in foreign exchange rates in the translation of local currency results into U.S. dollars. Accordingly, for purposes of estimating earnings per share growth, full year 2014 estimated local currency results, which include the impact of estimated foreign currency transaction gains and losses, are translated into U.S. dollars using 2013 average foreign exchange rates.
Cautionary Statement on Forward-Looking Statements
This press release and the related webcast may contain forward-looking
statements. Such statements may relate, for example, to sales or volume
growth, organic sales growth, profit or profit margin growth, earnings
growth, financial goals, the impact of currency devaluations, exchange
controls, price controls and labor unrest, including in
Non-GAAP Financial Measures
The following provides information regarding the non-GAAP financial measures used in this earnings release and/or the related webcast:
This release discusses organic sales growth, which is Net sales growth
excluding the impact of foreign exchange, acquisitions and divestments.
Management believes this measure provides investors with useful
supplemental information regarding the Company's underlying sales trends
by presenting sales growth excluding the external factor of foreign
exchange as well as the impact from acquisitions and divestments. See
"Geographic Sales Analysis Percentage Changes" for the three months
ended
To supplement Colgate's Condensed Consolidated Income Statements
presented in accordance with GAAP, the Company has disclosed non-GAAP
measures of operating results that exclude certain items. Worldwide
Gross profit, Gross profit margin, Selling, general and administrative
expenses, Selling, general and administrative expenses as a percentage
of Net sales, Other (income) expense, net, Operating profit, Operating
profit margin, Net income attributable to
The Company uses these financial measures internally in its budgeting process and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company's business, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. In addition, these non-GAAP financial measures may not be the same as similar measures presented by other companies.
The Company defines free cash flow before dividends as Net cash provided
by operations less Capital expenditures. As management uses this measure
to evaluate the Company's ability to satisfy current and future
obligations, repurchase stock, pay dividends and fund future business
opportunities, the Company believes that it provides useful information
to investors. Free cash flow before dividends is not a measure of cash
available for discretionary expenditures since the Company has certain
non-discretionary obligations such as debt service that are not deducted
from the measure. Free cash flow before dividends is not a GAAP
measurement and may not be comparable to similarly titled measures
reported by other companies. See "Condensed Consolidated Statements of
Cash Flows" for the three months ended
(See attached tables for first quarter results.)
Table 1 |
|||||||||||||
|
|||||||||||||
|
|||||||||||||
Condensed Consolidated Income Statements | |||||||||||||
For the Three Months Ended |
|||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||
2014 | 2013 | ||||||||||||
Net sales | $ | 4,325 | $ | 4,315 | |||||||||
Cost of sales | 1,801 | 1,800 | |||||||||||
Gross profit | 2,524 | 2,515 | |||||||||||
Gross profit margin | 58.4 | % | 58.3 | % | |||||||||
Selling, general and administrative expenses | 1,544 | 1,536 | |||||||||||
Other (income) expense, net | 346 | 237 | |||||||||||
Operating profit | 634 | 742 | |||||||||||
Operating profit margin | 14.7 | % | 17.2 | % | |||||||||
Interest (income) expense, net | 7 | (3 | ) | ||||||||||
Income before income taxes | 627 | 745 | |||||||||||
Provision for income taxes | 195 | 239 | |||||||||||
Effective tax rate | 31.1 | % | 32.1 | % | |||||||||
Net income including noncontrolling interests | 432 | 506 | |||||||||||
Less: Net income attributable to noncontrolling interests | 44 | 46 | |||||||||||
Net income attributable to |
$ | 388 | $ | 460 | |||||||||
Earnings per common share | |||||||||||||
Basic | $ | 0.42 | $ | 0.49 | |||||||||
Diluted | $ | 0.42 | $ | 0.48 | |||||||||
Average common shares outstanding | |||||||||||||
Basic | 919.5 | 936.6 | |||||||||||
Diluted | 928.6 | 945.0 | |||||||||||
Table 2 |
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
Condensed Consolidated Balance Sheets | |||||||||||||||||||
As of |
|||||||||||||||||||
(Dollars in Millions) (Unaudited) | |||||||||||||||||||
|
|
|
|||||||||||||||||
2014 | 2013 | 2013 | |||||||||||||||||
Cash and cash equivalents | $ | 1,795 | $ | 962 | $ | 932 | |||||||||||||
Receivables, net | 1,670 | 1,636 | 1,808 | ||||||||||||||||
Inventories | 1,478 | 1,425 | 1,371 | ||||||||||||||||
Other current assets | 734 | 799 | 717 | ||||||||||||||||
Property, plant and equipment, net | 4,037 | 4,083 | 3,820 | ||||||||||||||||
Other assets, including goodwill and intangibles | 4,718 | 4,971 | 4,885 | ||||||||||||||||
Total assets | $ | 14,432 | $ | 13,876 | $ | 13,533 | |||||||||||||
Total debt | $ | 6,659 | $ | 5,657 | $ | 5,357 | |||||||||||||
Other current liabilities | 3,782 | 3,562 | 3,829 | ||||||||||||||||
Other non-current liabilities | 2,091 | 2,121 | 2,328 | ||||||||||||||||
Total liabilities | 12,532 | 11,340 | 11,514 | ||||||||||||||||
|
1,630 | 2,305 | 1,772 | ||||||||||||||||
Noncontrolling interests | 270 | 231 | 247 | ||||||||||||||||
Total liabilities and shareholders' equity | $ | 14,432 | $ | 13,876 | $ | 13,533 | |||||||||||||
Supplemental Balance Sheet Information | |||||||||||||||||||
Debt less cash, cash equivalents and marketable securities* | $ | 4,621 | $ | 4,522 | $ | 4,261 | |||||||||||||
Working capital % of sales | (0.8 | )% | 0.7 | % | (0.5 | )% | |||||||||||||
* |
Marketable securities of |
Table 3 |
||||||||||||
|
||||||||||||
|
||||||||||||
Condensed Consolidated Statements of Cash Flows | ||||||||||||
For the Three Months Ended |
||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
2014 | 2013 | |||||||||||
Operating Activities | ||||||||||||
Net income including noncontrolling interests | $ | 432 | $ | 506 | ||||||||
Adjustments to reconcile net income including noncontrolling
interests to net cash provided by |
||||||||||||
Depreciation and amortization | 108 | 110 | ||||||||||
Restructuring and termination benefits, net of cash | 45 | 30 | ||||||||||
|
266 | 172 | ||||||||||
Stock-based compensation expense | 34 | 32 | ||||||||||
Deferred income taxes | (21 | ) | (17 | ) | ||||||||
Cash effects of changes in: | ||||||||||||
Receivables | (77 | ) | (175 | ) | ||||||||
Inventories | (67 | ) | (15 | ) | ||||||||
Accounts payable and other accruals | 100 | 112 | ||||||||||
Other non-current assets and liabilities | - | 22 | ||||||||||
Net cash provided by operations | 820 | 777 | ||||||||||
Investing Activities | ||||||||||||
Capital expenditures | (168 | ) | (94 | ) | ||||||||
Purchases of marketable securities and investments | (151 | ) | (199 | ) | ||||||||
Proceeds from sale of marketable securities and investments | 74 | 54 | ||||||||||
Payment for acquisitions, net of cash acquired | (25 | ) | - | |||||||||
Other | 21 | 7 | ||||||||||
Net cash used in investing activities | (249 | ) | (232 | ) | ||||||||
Financing Activities | ||||||||||||
Principal payments on debt | (1,938 | ) | (1,436 | ) | ||||||||
Proceeds from issuance of debt | 2,960 | 1,553 | ||||||||||
Dividends paid | (316 | ) | (290 | ) | ||||||||
Purchases of treasury shares | (453 | ) | (385 | ) | ||||||||
Proceeds from exercise of stock options and excess tax benefits | 50 | 96 | ||||||||||
Net cash provided by (used in) financing activities |
303 | (462 | ) | |||||||||
Effect of exchange rate changes on Cash and cash equivalents | (41 | ) | (35 | ) | ||||||||
Net increase (decrease) in Cash and cash equivalents | 833 | 48 | ||||||||||
Cash and cash equivalents at beginning of period | 962 | 884 | ||||||||||
Cash and cash equivalents at end of period | $ | 1,795 | $ | 932 | ||||||||
Supplemental Cash Flow Information | ||||||||||||
Free cash flow before dividends (Net cash provided by operations less Capital expenditures) | ||||||||||||
Net cash provided by operations | $ | 820 | $ | 777 | ||||||||
Less: Capital expenditures | (168 | ) | (94 | ) | ||||||||
Free cash flow before dividends | $ | 652 | $ | 683 | ||||||||
Income taxes paid | $ | 171 | $ | 182 | ||||||||
Table 4 |
||||||||||||
|
||||||||||||
|
||||||||||||
Segment Information | ||||||||||||
For the Three Months Ended |
||||||||||||
(Dollars in Millions) (Unaudited) | ||||||||||||
Three Months Ended
|
||||||||||||
2014 | 2013 | |||||||||||
Net Sales |
||||||||||||
Oral, Personal and Home Care | ||||||||||||
|
$ | 785 | $ | 764 | ||||||||
|
1,152 | 1,214 | ||||||||||
|
865 | 848 | ||||||||||
Asia | 672 | 655 | ||||||||||
|
298 | 300 | ||||||||||
Total Oral, Personal and Home Care | 3,772 | 3,781 | ||||||||||
Pet Nutrition | 553 | 534 | ||||||||||
Total Net Sales |
$ | 4,325 | $ | 4,315 | ||||||||
Three Months Ended
|
||||||||||||
2014 | 2013 | |||||||||||
Operating Profit |
||||||||||||
Oral, Personal and Home Care | ||||||||||||
|
$ | 216 | $ | 215 | ||||||||
|
290 | 312 | ||||||||||
|
217 | 200 | ||||||||||
Asia | 193 | 186 | ||||||||||
|
59 | 62 | ||||||||||
Total Oral, Personal and Home Care | 975 | 975 | ||||||||||
Pet Nutrition | 144 | 136 | ||||||||||
Corporate(1) | (485 | ) | (369 | ) | ||||||||
Total Operating Profit | $ | 634 | $ | 742 | ||||||||
(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation costs and gains and losses on sales of non-core product lines and assets.
Corporate Operating profit (loss) for the three months ended
Table 5 |
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
Geographic Sales Analysis Percentage Changes | |||||||||||||||||||||||||||||||
For the Three Months Ended |
|||||||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||||||
COMPONENTS OF SALES CHANGE | |||||||||||||||||||||||||||||||
Pricing | |||||||||||||||||||||||||||||||
Coupons | |||||||||||||||||||||||||||||||
Sales | 3 Months | Consumer & | |||||||||||||||||||||||||||||
Change | Organic | As Reported | Organic | Ex-Divested | Trade | Foreign | |||||||||||||||||||||||||
Region |
As Reported |
Sales Change |
Volume |
Volume |
Volume |
Incentives |
Exchange |
||||||||||||||||||||||||
|
- | % | 6.5 | % | 5.0 | % | 5.0 | % | 5.0 | % | 1.5 | % | (6.5 | %) | |||||||||||||||||
|
2.0 | % | 1.5 | % | 3.5 | % | 4.0 | % | 4.0 | % | (2.5 | %) | 1.0 | % | |||||||||||||||||
|
(5.0 | %) | 11.0 | % | 4.5 | % | 4.5 | % | 4.5 | % | 6.5 | % | (16.0 | %) | |||||||||||||||||
Asia | 2.5 | % | 7.5 | % | 7.0 | % | 7.0 | % | 7.0 | % | 0.5 | % | (5.0 | %) | |||||||||||||||||
|
(0.5 | %) | 10.0 | % | 9.5 | % | 9.5 | % | 9.5 | % | 0.5 | % | (10.5 | %) | |||||||||||||||||
|
(1.0 | %) | 7.5 | % | 5.5 | % | 5.5 | % | 5.5 | % | 2.0 | % | (8.5 | %) | |||||||||||||||||
|
2.5 | % | 3.5 | % | 4.5 | % | 4.5 | % | 4.5 | % | (1.0 | %) | (1.0 | %) | |||||||||||||||||
Total CP Products | - | % | 6.5 | % | 5.0 | % | 5.0 | % | 5.0 | % | 1.5 | % | (6.5 | %) | |||||||||||||||||
Hill's | 3.5 | % | 5.5 | % | 3.5 | % | 3.5 | % | 3.5 | % | 2.0 | % | (2.0 | %) | |||||||||||||||||
Emerging Markets (1) | (1.5 | %) | 10.0 | % | 6.5 | % | 6.5 | % | 6.5 | % | 3.5 | % | (11.5 | %) | |||||||||||||||||
Developed Markets | 2.0 | % | 2.5 | % | 3.0 | % | 3.5 | % | 3.5 | % | (1.0 | %) | - | % | |||||||||||||||||
(1) Emerging Markets include |
Table 6 |
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
Non-GAAP Reconciliations | |||||||||||||||||
For the Three Months Ended |
|||||||||||||||||
(Dollars in Millions Except Per Share Amounts) (Unaudited) | |||||||||||||||||
Gross Profit | 2014 | 2013 | |||||||||||||||
Gross profit, GAAP | $ | 2,524 | $ | 2,515 | |||||||||||||
2012 Restructuring Program | 10 | 8 | |||||||||||||||
Costs related to the sale of land in |
1 | 4 | |||||||||||||||
Gross profit, non-GAAP | $ | 2,535 | $ | 2,527 | |||||||||||||
|
|||||||||||||||||
Gross Profit Margin | 2014 | 2013 | Change | ||||||||||||||
Gross profit margin, GAAP | 58.4 | % | 58.3 | % | 10 | ||||||||||||
2012 Restructuring Program | 0.2 | % | 0.2 | % | |||||||||||||
Costs related to the sale of land in |
- | % | 0.1 | % | |||||||||||||
Gross profit margin, non-GAAP | 58.6 | % | 58.6 | % | - | ||||||||||||
Selling, General and Administrative Expenses | 2014 | 2013 | |||||||||||||||
Selling, general and administrative expenses, GAAP | $ | 1,544 | $ | 1,536 | |||||||||||||
2012 Restructuring Program | (17 | ) | (8 | ) | |||||||||||||
Selling, general and administrative expenses, non-GAAP | $ | 1,527 | $ | 1,528 | |||||||||||||
|
|||||||||||||||||
Selling, General and Administrative Expenses as a Percentage of Net Sales | 2014 | 2013 | Change | ||||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, GAAP | 35.7 | % | 35.6 | % | 10 | ||||||||||||
2012 Restructuring Program | (0.4 | %) | (0.2 | %) | |||||||||||||
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP | 35.3 | % | 35.4 | % | (10 | ) | |||||||||||
Other (Income) Expense, Net | 2014 | 2013 | |||||||||||||||
Other (income) expense, net, GAAP | $ | 346 | $ | 237 | |||||||||||||
2012 Restructuring Program | (75 | ) | (50 | ) | |||||||||||||
|
(266 | ) | (172 | ) | |||||||||||||
Costs related to the sale of land in |
- | (1 | ) | ||||||||||||||
Other (income) expense, net, non-GAAP | $ | 5 | $ | 14 | |||||||||||||
Operating Profit | 2014 | 2013 | % Change | ||||||||||||||
Operating profit, GAAP | $ | 634 | $ | 742 | (15 | %) | |||||||||||
2012 Restructuring Program | 102 | 66 | |||||||||||||||
|
266 | 172 | |||||||||||||||
Costs related to the sale of land in |
1 | 5 | |||||||||||||||
Operating profit, non-GAAP | $ | 1,003 | $ | 985 | 2 | % | |||||||||||
|
|||||||||||||||||
Operating Profit Margin | 2014 | 2013 | Change | ||||||||||||||
Operating profit margin, GAAP | 14.7 | % | 17.2 | % | (250 | ) | |||||||||||
2012 Restructuring Program | 2.3 | % | 1.5 | % | |||||||||||||
|
6.2 | % | 4.0 | % | |||||||||||||
Costs related to the sale of land in |
- | % | 0.1 | % | |||||||||||||
Operating profit margin, non-GAAP | 23.2 | % | 22.8 | % | 40 | ||||||||||||
Net Income Attributable to |
2014 | 2013 | % Change | ||||||||||||||
Net income attributable to |
$ | 388 | $ | 460 | (16 | %) | |||||||||||
2012 Restructuring Program | 73 | 52 | |||||||||||||||
|
174 | 111 | |||||||||||||||
Costs related to the sale of land in |
1 | 3 | |||||||||||||||
Net income attributable to |
$ | 636 | $ | 626 | 2 | % | |||||||||||
Diluted Earnings Per Common Share (1) (2) |
2014 | 2013 | % Change | ||||||||||||||
Diluted earnings per common share, GAAP | $ | 0.42 | $ | 0.48 | (13 | %) | |||||||||||
2012 Restructuring Program | 0.07 | 0.06 | |||||||||||||||
|
0.19 | 0.12 | |||||||||||||||
Costs related to the sale of land in |
- | - | |||||||||||||||
Diluted earnings per common share, non-GAAP | $ | 0.68 | $ | 0.66 | 3 | % | |||||||||||
(1) The impact of non-GAAP adjustments on the diluted earnings per share may not necessarily equal the difference between "GAAP" and "non-GAAP" as a result of rounding.
(2) Diluted earnings per share were computed independently for each quarter and the year to date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not necessarily equal the earnings per share for the year-to-date period.
Source:
News Provided by Acquire Media